• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Amazon will sell an exclusive brand of home health products called Choice, made by Arcadia Group

Share:

October 28, 2018

Highlights on this story:
  • A company called Arcadia Group says it created an exclusive new brand for Amazon called Choice, where it sells medical devices.
  • These devices include blood pressure cuffs and glucose monitors.
  • Amazon is ramping up its marketplace of health products.

A health brand consultancy called Arcadia Group has teamed up with Amazon to sell a new brand of consumer-focused medical devices, including blood pressure cuffs and glucose monitors, exclusively on the e-commerce giant’s marketplace.

The move is part of Amazon’s recent push to sell more exclusive brands on its website. It also dovetails with Amazon’s increasing interest in health and wellness products and services, although Arcadia initiated this project.

“I approached Amazon last year as they began to expand their health-care footprint,” Arcadia CEO Bob Guest said in a phone interview. “I felt that something that was missing from their offerings was products for people with diabetes and other chronic disease states.”

Arcadia on Thursday announced that the brand for Amazon is called Choice, and that it sells things like blood pressure cuffs and glucose monitors for millions of people with hypertension and diabetes. In the U.S. alone, about 30 million people have been diagnosed with diabetes, and 1 in 3 have high blood pressure.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Guest said his company will retain the brand but sell the products only on Amazon. Arcadia Group has developed similar health brands for Walmart and other companies.

“Choice is exclusive to Amazon but is not an Amazon private-label brand,” an Amazon spokesperson told CNBC, explaining that the brand owner is in charge of the design and production.

Guest also says he’s hoping to incorporate the devices his company sells with Amazon’s Echo home speaker devices in coming months, which would help users manage their disease with Amazon’s voice assistant Alexa. Amazon is ramping up the health and wellness team within Alexa but has not yet updated the device to be in compliance with federal privacy policies that govern how health information is stored and shared, called HIPAA.

Arcadia’s Choice website also has a page where it asks people to vote on which health products it should offer next, with options such as heart rate monitors and insulin pens.

Amazon has been ramping up its private label and exclusive business in recent years, and now has over 120 brands that sell exclusively on its marketplace, according to TJI Research. SunTrust Robinson Humphrey estimates Amazon increased the number of those brands by more than nine-fold since early 2016 and is on pace to generate $25 billion in sales by 2022, up from $7.5 billion in 2018.

Amazon has been giving some private label products more exposure across its site. They now show up high in search results under a separate box titled “Top Rated from Our Brands.” In recent months, Amazon has also been testing a feature that promotes its own private label brands at the bottom of its competitors’ product listings.

The company has also started selling more medical products on its marketplace, including hospital supplies and over-the-counter consumer health products.

It has a business team dedicated to selling medical supplies to physician practices and hospitals, a health team within Alexa, an internal health R&D team called Grand Challenges and a pharmacy group under PillPack, which it acquired in June. It’s also working with J.P. Morgan and Berkshire Hathaway to rethink health care for its own workers.

Date: October 29, 2018

Source: CNBC

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • How Intelligent Automation Can Address 3 Revenue Cycle ChallengesHow Intelligent Automation Can Address 3 Revenue Cycle Challenges
  • JATT Acquisition Corp’s Proposed Business Combination With Zura Bio Limited Declared Effective by US SECJATT Acquisition Corp’s Proposed Business Combination With Zura Bio Limited Declared Effective by US SEC
  • Gout Drugs Market 2021 | Swot Analysis and Key DevelopmentGout Drugs Market 2021 | Swot Analysis and Key Development
  • 7Wireventures & EHIR Partner to Accelerate the Adoption of Digital Health Solutions7Wireventures & EHIR Partner to Accelerate the Adoption of Digital Health Solutions
  • Sterling Bay Completes Purchase of Lurie Children’s Stanley Manne Children’s Research InstituteSterling Bay Completes Purchase of Lurie Children’s Stanley Manne Children’s Research Institute
  • Experts Seek Tweaks To FDA Draft Guidance On Clinical Trial DiversityExperts Seek Tweaks To FDA Draft Guidance On Clinical Trial Diversity
  • Samsung, HealthTap Partner to Bring Digital Healthcare to Smart TVsSamsung, HealthTap Partner to Bring Digital Healthcare to Smart TVs
  • DiaSorin to Acquire Luminex Corporation for USD 37.00 Per Share or Approximately USD 1.8 BillionDiaSorin to Acquire Luminex Corporation for USD 37.00 Per Share or Approximately USD 1.8 Billion

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications